Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.44 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL20456925 | 1.00 | CA4 (0.59) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL119893 | 1.00 | CA4 (0.59) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL275858 | 1.00 | CA4 (0.59) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL31726489 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL3871318 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL275857 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL3998452 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL15323424 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL3998443 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 | |
| Citric Acid SCHEMBL1154430 | 0.98 | CA4 (0.57) | CA4MEN1LMNAKMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363417-A1 | PRODUCTS AND METHODS FOR INCREASING NITRIC OXIDE PRODUCTION AND MANAGING OXIDATIVE STRESS | CORPORATION, KENT (US) | 2023-11-16 | — | — | US | claimed |
| CN-110462054-B | perfusion medium | 勃林格殷格翰国际公司 | 2023-11-10 | — | — | CN | claimed |
| WO-2022040590-A1 | PRODUCTS AND METHODS FOR INCREASING NITRIC OXIDE PRODUCTION AND MANAGING OXIDATIVE STRESS | KENT CORPORATION (US) | 2022-02-24 | — | — | WO | claimed |
| WO-2021137780-A1 | PREPARATION OF FILM TABLET COMPOSITION COMPRISING HEME IRON FOR IRON DEFICIENCY | İLKO İLAÇ SANAYİ VE TİCARET A.Ş. (TR) | 2021-07-08 | — | — | WO | claimed |
| WO-2020187420-A1 | COMPLEX IRON CONTAINING CULTURE MEDIUM | FLORABIO TEKNOLOJI SANAYI VE TICARET A.S. (TR) | 2020-09-24 | — | — | WO | claimed |
| US-9913806-B2 | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron | FE3 MEDICAL, INC. (US) | 2018-03-13 | — | — | US | claimed |
| US-9731982-B2 | Surface modified ceramic filter | UNIVERSITY OF KANSAS (US) | 2017-08-15 | — | — | US | claimed |
| EP-3103510-A1 | SYSTEM FOR TRANSDERMAL IONTOPHORETIC DELIVERY OF CHELATED AGENTS | Incube Labs, Llc (US) | 2016-12-14 | — | — | EP | claimed |
| EP-2320885-B1 | PATCHES FOR THE TRANSDERMAL DELIVERY OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF IRON | FE3 MEDICAL INC (US) | 2016-10-19 | — | — | EP | claimed |
| EP-2421601-B1 | SYSTEM FOR TRANSDERMAL IONTOPHORETIC DELIVERY OF CHELATED AGENTS | INCUBE LABS LLC (US) | 2016-06-15 | — | — | EP | claimed |
| US-20090035385-A1 | COMPOSITIONS INCLUDING IRON | DRUGTECH CORPORATION (US) | 2009-02-05 | — | — | US | claimed |
| EP-1996030-A1 | DOUBLE-FORTIFIED SALT AND PREPARATION PROCESS THEREFOR | Akzo Nobel N.V. (NL) | 2008-12-03 | — | — | EP | claimed |
| WO-2007107501-A1 | DOUBLE-FORTIFIED SALT AND PREPARATION PROCESS THEREFOR | AKZO NOBEL N.V. (NL) | 2007-09-27 | — | — | WO | claimed |
| EP-1827418-A2 | COMPOSITIONS INCLUDING IRON | Drugtech Corporation (US) | 2007-09-05 | — | — | EP | claimed |
| EP-1827419-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | Drugtech Corporation (US) | 2007-09-05 | — | — | EP | claimed |
| WO-2006068697-A2 | COMPOSITIONS INCLUDING IRON | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| WO-2006068729-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060134227-A1 | Compositions including iron | DRUGTECH CORPORATION | 2006-06-22 | — | — | US | claimed |
| WO-2003086321-A2 | MODIFIED RELEASE MINERALS | DRUGTECH CORPORATION (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030190355-A1 | Modified release minerals | DRUGTECH CORPORATION | 2003-10-09 | — | — | US | claimed |